THREE CASE-STUDY DRIVEN EVENTS UNDER ONE ROOF SHOWCASING BEST PRACTICES FOR ENHANCED DRUG DEVELOPMENT AND BUSINESS INSIGHTS THROUGH THE NEW WAVE OF INNOVATION IN DATA & ANALYTICS, REAL WORLD DATA & REAL WORLD EVIDENCE
The opportunity and promise of real world data is real, and pharmaceutical manufacturers have only just skimmed the surface of the unprecedented potential of Data & Analytics, Real World Data & Real World Evidence. DataRev18 will aid you in realizing the true value brought about by the data revolution - the only Congress aiming to break down the organizational silos in order to facilitate a seamless and free flow movement of data, throughout the life cycle from Clinical all the way through Commercial – aiding your business in truly embracing Data Driven Decision Making.
Given the value at stake, manufacturers have accelerated their capabilities by adopting real world data in facets of their organization, with RWD projects to inform commercial decisions as well as leverage RWD in clinical trials. However not one organization has truly applied big data strategies to holistically inform decision making throughout the drug development process, this is where we come in.
World Congress’ DataRev Congress aims to do just that, bringing together under one roof three disparate groups working towards the same objective, to comprehensively utilize the benefits brought about by real world in order to develop drugs faster and more effectively, ensure they are approved and reimbursed in a timely manner, therefore, accelerating the pace at which these drugs reach the patient.